Muslim World League, Catholic university sign cooperation agreement

Dr. Mohammed bin Abdulkarim Al-Issa, secretary-general of the Muslim World League, and UCSC Rector Franco Anelli during the signing of a partnership agreement in Rome. (SPA)
Short Url
Updated 21 January 2020

Muslim World League, Catholic university sign cooperation agreement

ROME: Upon his recent invitation to the Università Cattolica del Sacro Cuore (UCSC), the secretary-general of the Muslim World League (MWL) presented a lecture on friendship between nations and peoples. 

Dr. Mohammed bin Abdulkarim Al-Issa cited many examples of the positive relationship between the Islamic and Christian worlds, a relationship that has been recently reinforced through increased dialogue between the MWL and the Vatican. He emphasized the importance of cooperation based on mutual values and natural law. 

Al-Issa announced the launch of a global initiative that the MWL will be working on to further positive relations across religious and national divides. 

He spoke on the value of friendship, lamenting the various factors that threaten bonds between people, including political and religious extremism. 

Friendship

Al-Issa praised his friendship with Bishop Miguel Ayuso Guixot, president of the Pontifical Council for Interreligious Dialogue, saying he was happy to see him visit Saudi Arabia and meet with King Salman. 

Al-Issa and UCSC Rector Franco Anelli signed a partnership agreement between the MWL and the university that aims to develop and improve Arabic-language programs and Arab and Islamic cultural research activities at the university. 

In recent years, the Catholic university has undertaken various initiatives to promote Arabic language and culture.  

Research

Through this partnership, the MWL and the UCSC seek to enhance research in these fields, with plans to implement theoretical and applied research programs at the university’s Arabic Language Research Center. 


Major Saudi research center prepares to take part in advanced COVID-19 vaccine trials

Updated 22 September 2020

Major Saudi research center prepares to take part in advanced COVID-19 vaccine trials

  • Ministry of Health and King Abdullah International Medical Research Center have been working with two Chinese drug companies

JEDDAH: King Abdullah International Medical Research Center (KAIMRC) in Saudi Arabia is preparing to take part in advanced trials of one or two COVID-19 vaccines.

About 40 potential vaccines are being tested on humans, nine of which are at the advanced stage of clinical trials to evaluate their safety and effectiveness in protecting people against a virus that has infected more than 31 million people around the world.

The center confirmed its readiness to cooperate with the Kingdom’s Ministry of Health and the Saudi Food and Drug Authority (SFDA) and participate in tests of one or two of the nine vaccines that are in the third phase of clinical trials, during which large-scale testing on humans takes place.

Dr. Naif Al-Harbi, the head of KAIMRC’s drug-development unit, told Al-Ekhbariya TV news channel that it is unprecedented to have nine vaccines in stage three of clinical trials so soon, less than a year, after the emergence of a new virus.

“Approval or disapproval of any drug normally follows the third stage of its clinical trials, which is the last stage,” he added. “Since the pandemic, KAIMRC has been in continuous contact with a number of drug companies in four countries (that are developing vaccines).”

KAIMRC has been working with one Chinese pharmaceutical company in particular to help evaluate and accelerate the development of its vaccine, he said.

“Over the past two months, we have been in contact with Sinovac to scientifically evaluate its product, in term of the tests on animals and a study of the results of stages one and two on humans,” Al-Harbi said.